driving its rise as the world’s fourth-largest specialty generic pharmaceuticals company and the top player in India. This line of thinking inspired Sun Pharma to consolidate its six HR systems ...

both Sun Pharma and Ranbaxy will have to obtain approvals from BSE and NSE before proceeding for further clearances from various institutions such as Competition Commission of India and respective ...

Sun Pharma is ... Israel-based unit Taro Pharmaceutical Industries in order to integrate the dermatology business with itself and keep it profitable amid increasing competition in the segment ...

Bengaluru: Sun Pharmaceutical Industries Ltd, India's largest drugmaker ... diversifying from generic business amid intense price competition, entering the high-margin specialty segment about ...

The Competition Commission of India (CCI) has approved the acquisition of up to 76.10 percent of the voting share capital of Suven Pharmaceuticals Limited by Berhyanda Limited. The proposed ...

India's Sun Pharmaceutical has signed an agreement ... so will face heavyweight competition, although Sun reckons it is a "best in class" therapy. Lilly reached the market first with its JAK ...

Despite operating in one of the fastest growing markets, most multinational pharma companies are downsizing in India ... In addition to intense competition in sales and marketing, the MNC players ...